| Literature DB >> 30257676 |
Seung-Chai Kim1, Salik Nazki1, Sam Kwon1, Jhung-Hyun Juhng1, Kyeong-Hwan Mun1, Do-Young Jeon1, Chang-Gi Jeong1, Amina Khatun1, Seog-Jin Kang2, Won-Il Kim3.
Abstract
BACKGROUND: Porcine circovirus-associated diseases (PCVAD), caused by porcine circovirus type 2 (PCV2), threaten the pig industry worldwide. Five genotypes of PCV2 were recently identified: PCV2a, PCV2b, PCV2c, PCV2d and PCV2e. In addition, a novel porcine circovirus from a case of a sow with dermatitis, nephropathy syndrome and reproductive failure has been identified based on metagenomic analysis and classified as porcine circovirus type 3 (PCV3). Therefore, the current study was conducted to determine the prevalence and genetic characteristics of PCV2 and PCV3 in clinical samples.Entities:
Keywords: Genetic characteristics; Genotyping; PCV2; PCV3; Prevalence
Mesh:
Year: 2018 PMID: 30257676 PMCID: PMC6158811 DOI: 10.1186/s12917-018-1614-x
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Primers used in this study
| Primer name | Nucleotide sequence (5′ - 3′) | Product size | Purpose | Reference |
|---|---|---|---|---|
| F-PCV2C | GCT GGC TGA ACT TTT GAA AGT | 1767 bp | PCV2 detection and sequencing | L. Li et al., 2016 |
| R-PCV2C | AAA TTT CTG ACA AAC GTT ACA | |||
| PCV2ab 2NF | GGT TGG AAG TAA TCA ATA GTG GA | 277 bp | PCV2a-specific | T. Kwon et al., 2017 |
| PCV2a 2NR | GGG GAA CCA ACA AAA TCT C | Hesse et al., 2008 | ||
| PCV2ab 2NF | GGT TGG AAG TAA TCA ATA GTG GA | 277 bp | PCV2b-specific | T. Kwon et al., 2017 |
| PCV2b 2NR | GGG GCT CAA ACC CCC GCT C | Hesse et al., 2008 | ||
| PCV2d 2NF | GGT TGG AAG TAA TCG ATT GTC CT | 343 bp | PCV2d-specific | T. Kwon et al., 2017 |
| PCV2d 2NR | TCA GAA CGC CCT CCT GGA AT | |||
| PCV3–1-F | TTA CTT AGA GAA CGG ACT TGT AAC G | 649 bp | PCV3 detection | Ku et al., 2016 |
| PCV3–1-R | AAA TGA GAC ACA GAG CTA TAT TCA G | |||
| PCV3-genome-2-F | TTG CAC TTG TGT ACA ATT ATT GCG | 1075 bp | PCV3 sequencing | Ku et al., 2016 |
| PCV3-genome-2-R | ATC TTC AGG ACA CTC GTA GCA CCA C |
PCR results for genotyping of PCV2-positive serum and tissue samples
| Sample type | PCV2 genotype | Number of samples | Number of farms | PCV3 co-infection (samples/farms) | ||
|---|---|---|---|---|---|---|
| Serum Samples | 2a | 1 | (1/30, 3.3%) | 1 | (1/25, 4%) | 1 (1/1, 100%) /1 (1/1, 100%) |
| 2b | 1 | (1/30, 3.3%) | 1 | (1/25, 4%) | 0 | |
| 2d | 25 | (25/30, 83.3%) | 20 | (20/25, 80%) | 4 (4/25, 16%) /4 (4/20, 20%) | |
| 2b, 2d | 3 | (3/30, 10%) | 3 | (3/25, 12%) | 1 (1/3, 33.3%) /1 (1/3, 33%) | |
| Tissue Samples | 2a | 8 | (8/141, 5%) | 1 | (1/34, 2.9%) | 0 |
| 2b | 5 | (5/141, 3.1%) | 1 | (1/34, 2.9%) | 0 | |
| 2d | 82 | (82/141, 51.3%) | 17 | (17/34, 50%) | 6 (6/82, 7.3%) /3 (3/17, 17.6%) | |
| 2a, 2b | 1 | (1/141, 0.6%) | 1 | (1/34, 2.9%) | 1 (1/1, 100%) /1 (1/1, 100%) | |
| 2a, 2d | 20 | (20/141, 12.5%) | 3 | (3/34, 8.8%) | 1 (1/20, 5%) /1 (1/3, 33.3%) | |
| 2b, 2d | 16 | (16/141, 10%) | 8 | (8/34, 23.5%) | 0 | |
| 2a, 2b, 2d | 9 | (9/141, 5.6%) | 3 | (3/34, 8.8%) | 0 | |
Fig. 1Distribution of PCV2 and PCV3 infection by age group
Fig. 2Phylogenetic trees of PCV2 ORF2 sequences constructed using the maximum-likelihood method based on the generalized time-reversible (GTR) model with G + I in MEGA 6.06. Bootstrap values were calculated with 1000 replicates. Filled circles indicate the PCV2 strains identified in this study
Average nucleotide sequence homology within and between PCV2 genotypes
| Nucleotide homology within genotypes (%) | Nucleotide homology between PCV2 genotypes (%) | |||
|---|---|---|---|---|
| Genotype | PCV2a | PCV2b | PCV2d | |
| 99.4 ± 0.2 (99.1–99.6) | PCV2a | – | – | – |
| 98.7 ± 0.5 (98.1–99.4) | PCV2b | 91.4 ± 0.3 (91.0–92.0) | – | – |
| 99.5 ± 0.3 (98.6–100) | PCV2d | 90.4 ± 0.2 (89.6–91.0) | 93.9 ± 0.3 (93.2–94.3) | – |
Homology was determined by the maximum-likelihood method based on the GTR model with G + I in MEGA 6.06 software. Bootstrap values were calculated with 1000 replicates. The analysis includes Korean ORF2 sequences isolated after 2015
PCR results for PCV3-positive serum and tissue samples
| Sample type | Number of samples | Number of farms | PRRS co-infection (samples/farms) | PCV2 co-infection (samples/farms) |
|---|---|---|---|---|
| Serum | 37 (37/286, 12.9%) | 20 (20/47, 42.6%) | 12 (12/37, 32.4%)/10 (10/20, 50%) | 4 (4/37, 10.8%)/4 (4/20, 20%) |
| Tissue | 20 (20/296, 6.8%) | 12 (12/91, 13.2%) | 13 (13/20, 65%)/10 (10/12, 83.3%) | 7 (7/20, 35%)/6 (6/12, 50%) |
| Aborted foetus | 2 (2/108, 1.9%) | 2 (2/26, 7.7%) | – | – |
Fig. 3Phylogenetic trees of PCV3 ORF2 sequences of Korean PCV3 constructed using the maximum-likelihood method based on the GTR model with G + I in MEGA 6.06. Bootstrap values were calculated with 1000 replicates. Filled circles indicate the PCV3 strains identified in this study
Average p-distances within and between PCV3 clades
| Average | Average | |||||||
|---|---|---|---|---|---|---|---|---|
| Genotype | Clade I | Clade II | Clade III | UG1 | UG2 | UG3 | UG4 | |
| 0.0065 ± 0.0035 | Clade I | – | – | – | – | – | – |
|
| 0.0079 ± 0.0045 | Clade II | 0.0144 ± 0.0027 | – | – | – | – | – |
|
| 0.0050 ± 0.0026 | Clade III | 0.0152 ± 0.0027 | 0.0155 ± 0.0030 | – | – | – | – |
|
| – | UG1 | 0.0136 ± 0.0025 | 0.0163 ± 0.0031 | 0.0150 ± 0.0019 | – | – | – |
|
| – | UG2 | 0.0132 ± 0.0022 | 0.0127 ± 0.0020 | 0.0134 ± 0.0019 | 0.0140 | – | – |
|
| – | UG3 | 0.0148 ± 0.0022 | 0.0143 ± 0.0020 | 0.0150 ± 0.0019 | 0.0155 | 0.0109 | – |
|
| – | UG4 | 0.0308 ± 0.0024 | 0.0293 ± 0.0017 | 0.0328 ± 0.0012 | 0.0341 | 0.0295 | 0.0279 |
|
The p-distance was determined by the neighbour-joining method based on the GTR model with G + I in MEGA 6.06 software. Bootstrap values were calculated with 1000 replicates. The analysis includes ORF2 sequences of 13 PCV3 Clade I, 15 PCV3 Clade II, 6 PCV3 Clade III and 4 ungrouped (UG) sequences (UG1 = KY996344.1, UG2 = CBNU-VDC160714, UG3 = KX898030.1 and UG4 = KY418606.1)